On Air Now

Now Playing

The Truth About Love Album Cover Try by P!nk
Our Playlist »

Listen

Listen Live Now » 101.9 FM Sioux Falls, SD

Weather

Current Conditions(Sioux Falls,SD 57104)

More Weather »
62° Feels Like: 62°
Wind: NW 26 mph Past 24 hrs - Precip: 0”
Current Radar for Zip

Tonight

Scattered Thunderstorms/Wind 47°

Tomorrow

AM Clouds/PM Sun 68°

Thurs Night

Mostly Clear 41°

AstraZeneca pays $50 million for rights to Merck cancer drug

(Reuters) - Merck & Co Inc has licensed its experimental cancer drug to AstraZeneca Plc for a $50 million upfront fee in a deal that shows Britain's second-biggest drugmaker continuing to rebuild its pipeline.

Under the terms of the agreement, Merck, the No. 2 U.S. drugmaker, will also be eligible to receive future payments related to development and regulatory milestones, as well as tiered royalties.

The drug, MK-1775, is currently in mid-stage trials in combination with standard-of-care therapies for the treatment of patients with certain types of ovarian cancer.

(Reporting by Shailesh Kuber; Editing by Sreejiraj Eluvangal)

Comments